Continuous Crystallization of Proteins in a Tubular Plug-Flow Crystallizer

被引:97
作者
Neugebauer, Peter [1 ]
Khinast, Johannes G. [1 ,2 ]
机构
[1] Graz Univ Technol, Inst Proc & Particle Engn, A-8010 Graz, Austria
[2] Res Ctr Pharmaceut Engn, Graz, Austria
基金
奥地利科学基金会;
关键词
EGG-WHITE LYSOZYME; GROWTH; TEMPERATURE; SOLUBILITY; STABILITY; NUCLEATION;
D O I
10.1021/cg501359h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Protein crystals have many important applications in many fields, including pharmaceutics. Being more stable than other formulations, and having a high degree of purity and bioavailability, they are especially promising in the area of drug delivery. In this contribution, the development of a continuously operated tubular crystallizer for the production of protein crystals has been described. Using the model enzyme lysozyme, we successfully generated product particles ranging between 15 and 40 mu m in size. At the reactor inlet, a protein solution was mixed with a crystallization agent solution to create high supersaturations required for nucleation. Along the tube, supersaturation was controlled using water baths that divided the crystallizer into a nucleation zone and a growth zone. Low flow rates minimized the effect of shear forces that may impede crystal growth. Simultaneously, a slug flow was implemented to ensure crystal transport through the reactor and to reduce the residence time distribution.
引用
收藏
页码:1089 / 1095
页数:7
相关论文
共 42 条
[1]   Using Temperature To Crystaltize Proteins: A Mini-Review [J].
Astier, Jean-Pierre ;
Veesler, Stephane .
CRYSTAL GROWTH & DESIGN, 2008, 8 (12) :4215-4219
[2]  
Basu SK, 2004, EXPERT OPIN BIOL TH, V4, P301, DOI 10.1517/eobt.4.3.301.27331
[3]   Modeling a seeded continuous crystallizer for the production of active pharmaceutical ingredients [J].
Besenhard, M. O. ;
Hohl, R. ;
Hodzic, A. ;
Eder, R. J. P. ;
Khinast, J. G. .
CRYSTAL RESEARCH AND TECHNOLOGY, 2014, 49 (2-3) :92-108
[4]   CHEMICAL-STABILITY OF INSULIN .1. HYDROLYTIC DEGRADATION DURING STORAGE OF PHARMACEUTICAL PREPARATIONS [J].
BRANGE, J ;
LANGKJAER, L ;
HAVELUND, S ;
VOLUND, A .
PHARMACEUTICAL RESEARCH, 1992, 9 (06) :715-726
[5]   THE SOLUBILITY OF THE TETRAGONAL FORM OF HEN EGG-WHITE LYSOZYME FROM PH 4.0 TO 5.4 [J].
CACIOPPO, E ;
PUSEY, ML .
JOURNAL OF CRYSTAL GROWTH, 1991, 114 (03) :286-292
[6]  
Chang BS., 2010, FORMULATION PROCESS, P69, DOI [DOI 10.1002/9780470595886.CH3, 10.1002/9780470595886.ch3.]
[7]   Temperature-dependent solubility of selected proteins [J].
Christopher, GK ;
Phipps, AG ;
Gray, RJ .
JOURNAL OF CRYSTAL GROWTH, 1998, 191 (04) :820-826
[8]   Cross-linked protein crystals for vaccine delivery [J].
Clair, NS ;
Shenoy, B ;
Jacob, LD ;
Margolin, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9469-9474
[9]  
DeFelippis M. R., 2012, PHARM FORMULATION DE
[10]   THERMAL METHODS FOR CRYSTALLIZING BIOLOGICAL MACROMOLECULES [J].
DEMATTEI, RC ;
FEIGELSON, RS .
JOURNAL OF CRYSTAL GROWTH, 1993, 128 (1-4) :1225-1231